Showing results (1-10 of 635) with videos related to
Sort By:
Pageof 64
Plos One|July 2, 2016
Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis PatientsYoshifumi Amari, Satoshi Morimoto, Fumitaka Nakajima, et al.Kidney & Blood Pressure Research|November 23, 2017
Effects of L- and N-Type Ca Channel Blocker Cilnidipine on Changes in Heart Rate and QT Interval During DialysisTakeshi Iida, Satoshi Morimoto, Yoshifumi Amari, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 20, 2020
Management of primary aldosteronism and mineralocorticoid receptor-associated hypertensionSatoshi Morimoto, Atsuhiro IchiharaCurrent Pharmaceutical Design|July 13, 2013
Novel approach to cardiovascular diseases: a promising probability of (pro)renin receptor [(P)RR]Takashi Ando, Atsuhiro IchiharaHypertension Research : Official Journal of the Japanese Society of Hypertension|December 28, 2021
Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronismToru Ishikawa, Satoshi Morimoto, Atsuhiro IchiharaWorld Journal of Nephrology|November 7, 2014
Roles of the (pro)renin receptor in the kidneyYoichi Oshima, Satoshi Morimoto, Atsuhiro IchiharaHypertension Research : Official Journal of the Japanese Society of Hypertension|March 29, 2024
Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronismMakiko Ikemoto, Satoshi Morimoto, Atsuhiro IchiharaPlos One|April 5, 2013
Association between soluble (Pro)renin receptor concentration in cord blood and small for gestational age birth: a cross-sectional studyNoriyoshi Watanabe, Satoshi Morimoto, Takeo Fujiwara, et al.Endocrine|February 15, 2025
Comparison of the clinical significance of lymphocyte-based inflammatory indices between the two major subtypes of primary aldosteronismDaisuke Watanabe, Satoshi Morimoto, Noriko Morishima, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 28, 2026
Clinical implications of aldosterone responsiveness to adrenocorticotropic hormone stimulation in two major subtypes of primary aldosteronismDaisuke Watanabe, Satoshi Morimoto, Noriko Morishima, et al.Pageof 64